Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

被引:251
|
作者
Bajetto, A
Bonavia, R
Barbero, S
Schettini, G
机构
[1] Adv Biotechnol Ctr, Inst Canc Res, Serv Pharmacol & Neurosci, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Sect, Genoa, Italy
关键词
acquired immune deficiency syndrome dementia complex; Alzheimer's disease; brain tumors; chemokines; multiple sclerosis; stroke;
D O I
10.1046/j.1471-4159.2002.01091.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines represent key factors in the outburst of the immune response, by activating and directing the leukocyte traffic, both in lymphopoiesis and in immune surveillance. Neurobiologists took little interest in chemokines for many years, until their link to acquired immune deficiency syndrome-associated dementia became established, and thus their importance in this field has been neglected. Nevertheless, the body of data on their expression and role in the CNS has grown in the past few years, along with a new vision of brain as an immunologically competent and active organ. A large number of chemokines and chemokine receptors are expressed in neurons, astrocytes, microglia and oligodendrocytes, either constitutively or induced by inflammatory mediators. They are involved in many neuropathological processes in which an inflammatory state persists, as well as in brain tumor progression and metastasis. Moreover, there is evidence for a crucial role of CNS chemokines under physiological conditions, similar to well known functions in the immune system, such as proliferation and developmental patterning, but also peculiar to the CNS, such as regulation of neural transmission, plasticity and survival.
引用
收藏
页码:1311 / 1329
页数:19
相关论文
共 50 条
  • [21] INSULIN RECEPTORS - IMPLICATIONS AND PHYSIOPATHOLOGICAL APPLICATIONS
    FREYCHET, P
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1976, 34 (05) : 365 - 370
  • [22] Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders
    Johnson, Chad R.
    Kangas, Brian D.
    Jutkiewicz, Emily M.
    Bergman, Jack
    Coop, Andrew
    [J]. BIOMEDICINES, 2022, 10 (02)
  • [23] TRYPTAMINE RECEPTORS IN CENTRAL NERVOUS SYSTEM
    VANE, JR
    BRADLEY, PB
    MARLEY, E
    COLLIER, HOJ
    CORNE, SJ
    [J]. NATURE, 1961, 191 (479) : 1068 - &
  • [24] Somatostatin receptors in the central nervous system
    Schindler, M
    Humphrey, PPA
    Emson, PC
    [J]. PROGRESS IN NEUROBIOLOGY, 1996, 50 (01) : 9 - +
  • [25] Mineralocorticoid receptors in the central nervous system
    Funder, JW
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 56 (1-6): : 179 - 183
  • [26] Lysophospholipids and their receptors in the central nervous system
    Choi, Ji Woong
    Chun, Jerold
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (01): : 20 - 32
  • [27] Role of cytokines and chemokines in prion infections of the central nervous system
    Burwinkel, M
    Riemer, C
    Schwarz, A
    Schultz, J
    Neidhold, S
    Bamme, T
    Baier, M
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2004, 22 (07) : 497 - 505
  • [28] Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids
    Roberta Gualtierotti
    Laura Guarnaccia
    Matteo Beretta
    Stefania E. Navone
    Rolando Campanella
    Laura Riboni
    Paolo Rampini
    Giovanni Marfia
    [J]. Advances in Therapy, 2017, 34 : 396 - 420
  • [29] Chemokines in systemic lupus erythematosus involving the central nervous system
    Kasama, Tsuyoshi
    Odai, Tsuyoshi
    Wakabayashi, Kuninobu
    Yajima, Nobuyuki
    Miwa, Yusuke
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 2527 - 2536
  • [30] Genomic Characterization of Central Nervous System Metastases: Implications for Precision Medicine
    Brastianos, Priscilla K.
    [J]. ONCOLOGIST, 2015, 20 : S2 - S2